Nxera Pharma Co Ltd
F:JSS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nxera Pharma Co Ltd
F:JSS
|
JP |
|
K
|
Kelly Services Inc
F:KYSA
|
US |
|
G
|
GRP Ltd
SGX:BLU
|
SG |
|
H
|
HanTech Ltd
KOSDAQ:098070
|
KR |
|
D
|
Dampskibsselskabet Norden A/S
DUS:D69
|
DK |
|
H
|
Havanna Holding SA
BCBA:HAVA
|
AR |
|
A
|
Advanced Connection Corporation PCL
SET:ACC
|
TH |
|
Tevano Systems Holdings Inc
F:7RBA
|
CA |
|
B
|
Bakrie & Brothers Tbk PT
XMUN:LFU2
|
ID |
|
M
|
Meglioquesto SpA
F:7V60
|
IT |
|
P
|
Public Service Enterprise Group Inc
XMUN:PSE
|
US |
|
P
|
Prymus SA
WSE:PRS
|
PL |
|
I
|
Industrial & Infrastructure Fund Investment Corp
F:2ES
|
JP |
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
M
|
Marriott International Inc
F:MAQ
|
US |
|
G
|
Great Eagle Holdings Ltd
XMUN:GHK
|
BM |
|
Avingtrans PLC
LSE:AVG
|
UK |
|
H
|
Heritage Mining Ltd
F:Y66
|
CA |
|
Littelfuse Inc
NASDAQ:LFUS
|
US |
|
M
|
Morien Resources Corp
OTC:APMCF
|
CA |
Bankruptcy Probability
Nxera Pharma Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Nxera Pharma Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JP |
N
|
Nxera Pharma Co Ltd
TSE:4565
|
110.8B JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
611.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
366.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
363.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
233.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
196.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
289.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
166.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Nxera Pharma Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Nxera Pharma Co Ltd has total debt of 47.7B JPY. This includes both short-term (777m JPY) and long-term (46.9B JPY) debt.
You can find a full breakdown on its Balance Sheet.